{"text": ["Top", "5", "Biotech", "Stocks", "for", "2018"], "created_at": "2018-07-11 23:05:00"}
{"text": ["Stocks", "to", "Watch:", "Boeing,", "Ford,", "American", "Airlines,", "JetBlue,", "Pfizer,", "Comcast,", "Alphabet,", "Nvidia,", "AbbVie"], "created_at": "2018-07-11 13:23:26"}
{"text": ["AbbVie", "Inc.", "(ABBV)", "Ex-Dividend", "Date", "Scheduled", "for", "July", "12,", "2018"], "created_at": "2018-07-11 13:16:48"}
{"text": ["AbbVie", "Inc.", "(ABBV)", "Ex-Dividend", "Date", "Scheduled", "for", "July", "12,", "2018"], "created_at": "2018-07-11 13:16:48"}
{"text": ["AbbVie&apos;s", "stock", "falls", "after", "lymphoma", "treatment", "trial", "data", "disappoints"], "created_at": "2018-07-11 12:15:00"}
{"text": ["AbbVie", "Provides", "Update", "on", "Phase", "3", "Study", "of", "Ibrutinib", "(IMBRUVICA\u00ae)", "in", "Blood", "Cancer", "Diffuse", "Large", "B-Cell", "Lymphoma", "(DLBCL)", "and", "Ongoing", "Ibrutinib", "Clinical", "Program"], "created_at": "2018-07-11 12:00:00"}
{"text": ["Ex-Dividend", "Alert:", "AbbVie", "Has", "Raised", "its", "Dividend", "By", "140%", "Since", "2013;", "Will", "Trade", "Ex-Dividend", "on", "July", "12,", "2018"], "created_at": "2018-07-11 11:05:00"}
{"text": ["AbbVie", "Updates", "On", "Phase", "3", "Study", "Of", "Ibrutinib", "In", "Blood", "Cancer", "DLBCL"], "created_at": "2018-07-11 08:09:00"}
{"text": ["AbbVie", "Updates", "On", "Phase", "3", "Study", "Of", "Ibrutinib", "In", "Blood", "Cancer", "DLBCL"], "created_at": "2018-07-11 08:09:00"}
